| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung | 40 | 2025 | 969 | 4.880 |
Why?
|
| Pneumonia, Bacterial | 15 | 2025 | 91 | 4.170 |
Why?
|
| Pneumonia | 12 | 2025 | 295 | 4.120 |
Why?
|
| STAT3 Transcription Factor | 12 | 2021 | 70 | 3.200 |
Why?
|
| Liver | 10 | 2024 | 874 | 2.060 |
Why?
|
| Pneumonia, Pneumococcal | 14 | 2022 | 27 | 2.060 |
Why?
|
| Neutrophils | 11 | 2025 | 396 | 2.000 |
Why?
|
| Escherichia coli Infections | 9 | 2015 | 90 | 1.870 |
Why?
|
| Transcription Factor RelA | 7 | 2019 | 51 | 1.490 |
Why?
|
| Lung Injury | 2 | 2022 | 36 | 1.440 |
Why?
|
| Streptococcus pneumoniae | 13 | 2024 | 67 | 1.420 |
Why?
|
| Acute-Phase Reaction | 5 | 2021 | 18 | 1.420 |
Why?
|
| Epithelial Cells | 8 | 2021 | 414 | 1.190 |
Why?
|
| Oncostatin M | 2 | 2021 | 3 | 1.140 |
Why?
|
| Animals | 63 | 2025 | 21459 | 1.080 |
Why?
|
| Neutrophil Infiltration | 6 | 2019 | 64 | 1.070 |
Why?
|
| Leukemia Inhibitory Factor | 3 | 2022 | 4 | 1.070 |
Why?
|
| Macrophages, Alveolar | 11 | 2022 | 65 | 1.060 |
Why?
|
| Immunity, Innate | 16 | 2021 | 829 | 1.050 |
Why?
|
| Klebsiella Infections | 5 | 2012 | 25 | 1.050 |
Why?
|
| Klebsiella pneumoniae | 5 | 2012 | 29 | 1.050 |
Why?
|
| Mice | 48 | 2025 | 11173 | 1.020 |
Why?
|
| Signal Transduction | 8 | 2024 | 3162 | 0.850 |
Why?
|
| Mice, Inbred C57BL | 29 | 2025 | 3500 | 0.830 |
Why?
|
| Scavenger Receptors, Class E | 1 | 2022 | 5 | 0.760 |
Why?
|
| Endotoxemia | 3 | 2021 | 11 | 0.690 |
Why?
|
| Coinfection | 1 | 2021 | 59 | 0.660 |
Why?
|
| Airway Remodeling | 3 | 2021 | 22 | 0.630 |
Why?
|
| Interleukin-11 | 1 | 2019 | 8 | 0.610 |
Why?
|
| Sepsis | 2 | 2024 | 302 | 0.610 |
Why?
|
| Pulmonary Edema | 1 | 2019 | 29 | 0.590 |
Why?
|
| Respiratory Mucosa | 5 | 2019 | 51 | 0.590 |
Why?
|
| Myeloid Cells | 4 | 2020 | 98 | 0.580 |
Why?
|
| Smoke | 1 | 2018 | 25 | 0.570 |
Why?
|
| Chemokine CXCL5 | 3 | 2025 | 9 | 0.560 |
Why?
|
| Pulmonary Alveoli | 4 | 2017 | 44 | 0.540 |
Why?
|
| Chemokines, CXC | 4 | 2007 | 33 | 0.540 |
Why?
|
| Bronchoalveolar Lavage Fluid | 11 | 2017 | 91 | 0.530 |
Why?
|
| Mice, Knockout | 11 | 2022 | 2168 | 0.510 |
Why?
|
| Escherichia coli | 7 | 2017 | 717 | 0.500 |
Why?
|
| Acute-Phase Proteins | 3 | 2015 | 35 | 0.500 |
Why?
|
| CD4-Positive T-Lymphocytes | 6 | 2025 | 642 | 0.500 |
Why?
|
| Immunologic Memory | 6 | 2025 | 284 | 0.480 |
Why?
|
| Interleukin-6 | 6 | 2009 | 323 | 0.460 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2005 | 157 | 0.440 |
Why?
|
| Macrophages | 7 | 2022 | 1041 | 0.420 |
Why?
|
| Disease Resistance | 1 | 2014 | 27 | 0.420 |
Why?
|
| NF-kappa B | 3 | 2017 | 435 | 0.410 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2019 | 604 | 0.390 |
Why?
|
| Hepatocytes | 2 | 2012 | 226 | 0.380 |
Why?
|
| Receptor, Adenosine A2B | 1 | 2012 | 11 | 0.380 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2014 | 74 | 0.380 |
Why?
|
| Transcriptome | 3 | 2025 | 405 | 0.370 |
Why?
|
| Mice, Transgenic | 10 | 2021 | 1291 | 0.370 |
Why?
|
| Endothelial Cells | 3 | 2024 | 215 | 0.360 |
Why?
|
| Acute Lung Injury | 1 | 2012 | 45 | 0.350 |
Why?
|
| Disease Models, Animal | 9 | 2025 | 2326 | 0.330 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2012 | 350 | 0.330 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 1633 | 0.320 |
Why?
|
| Lipopolysaccharides | 6 | 2021 | 625 | 0.310 |
Why?
|
| Cell Line | 8 | 2017 | 2029 | 0.310 |
Why?
|
| Host-Pathogen Interactions | 3 | 2021 | 279 | 0.290 |
Why?
|
| Ethanol | 3 | 2007 | 333 | 0.270 |
Why?
|
| Chemokine CXCL2 | 7 | 2016 | 16 | 0.270 |
Why?
|
| Interleukin-1 | 2 | 2009 | 154 | 0.260 |
Why?
|
| Cytokines | 6 | 2015 | 964 | 0.260 |
Why?
|
| RNA, Messenger | 13 | 2017 | 1580 | 0.250 |
Why?
|
| Inflammation | 5 | 2022 | 1195 | 0.250 |
Why?
|
| Macrophage Inflammatory Proteins | 2 | 2005 | 11 | 0.240 |
Why?
|
| Adaptive Immunity | 2 | 2018 | 105 | 0.230 |
Why?
|
| Apoptosis | 2 | 2022 | 1100 | 0.220 |
Why?
|
| Humans | 20 | 2025 | 65645 | 0.220 |
Why?
|
| Membrane Proteins | 2 | 2024 | 925 | 0.220 |
Why?
|
| Hypersensitivity | 1 | 2025 | 73 | 0.210 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 3 | 2005 | 41 | 0.210 |
Why?
|
| Gain of Function Mutation | 1 | 2024 | 20 | 0.210 |
Why?
|
| CD40 Ligand | 1 | 2024 | 159 | 0.200 |
Why?
|
| Th17 Cells | 2 | 2025 | 65 | 0.200 |
Why?
|
| Respiratory Tract Infections | 1 | 2024 | 90 | 0.200 |
Why?
|
| Chemokines | 5 | 2008 | 99 | 0.180 |
Why?
|
| Interleukin-27 | 1 | 2022 | 7 | 0.180 |
Why?
|
| Hookworm Infections | 1 | 2022 | 11 | 0.180 |
Why?
|
| Cell Movement | 1 | 2003 | 482 | 0.170 |
Why?
|
| Extracellular Traps | 1 | 2022 | 45 | 0.170 |
Why?
|
| DNA-Binding Proteins | 4 | 2012 | 1226 | 0.170 |
Why?
|
| Cells, Cultured | 4 | 2021 | 2189 | 0.170 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 2 | 1 | 2020 | 1 | 0.160 |
Why?
|
| Dinucleoside Phosphates | 1 | 2020 | 32 | 0.160 |
Why?
|
| Asthma | 1 | 2025 | 485 | 0.160 |
Why?
|
| Interferon-gamma | 4 | 2025 | 576 | 0.150 |
Why?
|
| Male | 15 | 2025 | 31292 | 0.150 |
Why?
|
| Trachea | 2 | 2011 | 83 | 0.150 |
Why?
|
| Antigen Presentation | 1 | 2021 | 239 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 4 | 2017 | 869 | 0.150 |
Why?
|
| Chemokine CCL2 | 1 | 2019 | 61 | 0.150 |
Why?
|
| Kupffer Cells | 1 | 2019 | 43 | 0.150 |
Why?
|
| Natural Killer T-Cells | 1 | 2019 | 30 | 0.150 |
Why?
|
| Neutrophil Activation | 2 | 2016 | 23 | 0.150 |
Why?
|
| Interleukins | 3 | 2022 | 88 | 0.150 |
Why?
|
| Proteomics | 1 | 2021 | 299 | 0.150 |
Why?
|
| Cell Survival | 1 | 2021 | 588 | 0.150 |
Why?
|
| Interleukin-17 | 4 | 2025 | 101 | 0.140 |
Why?
|
| Hematopoiesis | 2 | 2017 | 127 | 0.140 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 565 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2011 | 624 | 0.140 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 169 | 0.130 |
Why?
|
| Acute Disease | 1 | 2019 | 663 | 0.130 |
Why?
|
| Antibodies, Neutralizing | 1 | 2019 | 218 | 0.130 |
Why?
|
| Cell Differentiation | 3 | 2020 | 1389 | 0.130 |
Why?
|
| RNA Nucleotidyltransferases | 1 | 2017 | 11 | 0.130 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2017 | 8 | 0.130 |
Why?
|
| Immunity, Heterologous | 1 | 2017 | 11 | 0.130 |
Why?
|
| Pluripotent Stem Cells | 1 | 2017 | 72 | 0.130 |
Why?
|
| Necrosis | 1 | 2017 | 148 | 0.120 |
Why?
|
| Pneumococcal Infections | 2 | 2024 | 39 | 0.120 |
Why?
|
| Alcoholic Intoxication | 2 | 2007 | 27 | 0.120 |
Why?
|
| Argonaute Proteins | 1 | 2017 | 154 | 0.120 |
Why?
|
| Rats | 5 | 2011 | 1996 | 0.120 |
Why?
|
| Recombinant Proteins | 3 | 2016 | 708 | 0.120 |
Why?
|
| Microbiota | 1 | 2018 | 170 | 0.120 |
Why?
|
| Brain | 1 | 2024 | 1625 | 0.110 |
Why?
|
| Biomarkers | 1 | 2021 | 1487 | 0.110 |
Why?
|
| RNA-Binding Proteins | 2 | 2017 | 446 | 0.110 |
Why?
|
| Granulocytes | 2 | 2005 | 73 | 0.110 |
Why?
|
| Leukocyte Count | 2 | 2005 | 102 | 0.110 |
Why?
|
| MicroRNAs | 2 | 2012 | 714 | 0.110 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 741 | 0.110 |
Why?
|
| Smoking | 1 | 2018 | 863 | 0.100 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 1573 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2014 | 150 | 0.100 |
Why?
|
| Uridine | 1 | 2012 | 23 | 0.090 |
Why?
|
| Serum Amyloid P-Component | 1 | 2012 | 2 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 83 | 0.090 |
Why?
|
| Female | 8 | 2025 | 34309 | 0.090 |
Why?
|
| Serum Amyloid A Protein | 1 | 2012 | 7 | 0.090 |
Why?
|
| Antigens, Differentiation | 2 | 2023 | 144 | 0.090 |
Why?
|
| Gene Expression | 1 | 2015 | 854 | 0.090 |
Why?
|
| Immunoblotting | 1 | 2012 | 202 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 97 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 2 | 2009 | 205 | 0.090 |
Why?
|
| Chemokine CXCL1 | 1 | 2011 | 5 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 129 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 297 | 0.080 |
Why?
|
| Catheterization | 1 | 2011 | 111 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 898 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2010 | 200 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 792 | 0.080 |
Why?
|
| Uridine Monophosphate | 1 | 2009 | 8 | 0.080 |
Why?
|
| STAT1 Transcription Factor | 2 | 2007 | 35 | 0.070 |
Why?
|
| RAW 264.7 Cells | 2 | 2020 | 50 | 0.070 |
Why?
|
| Chemokine CCL4 | 2 | 2005 | 14 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2025 | 797 | 0.070 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2007 | 9 | 0.070 |
Why?
|
| Ozone | 1 | 2007 | 20 | 0.060 |
Why?
|
| Time Factors | 4 | 2017 | 3777 | 0.060 |
Why?
|
| Central Nervous System Depressants | 1 | 2007 | 46 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 858 | 0.060 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 50 | 0.060 |
Why?
|
| Leukocytes | 2 | 2021 | 110 | 0.060 |
Why?
|
| Monokines | 2 | 2004 | 4 | 0.060 |
Why?
|
| Opsonin Proteins | 1 | 2006 | 32 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 234 | 0.060 |
Why?
|
| Gram-Positive Bacteria | 1 | 2006 | 35 | 0.060 |
Why?
|
| Acrylic Resins | 1 | 2006 | 21 | 0.060 |
Why?
|
| Ligands | 2 | 2023 | 414 | 0.060 |
Why?
|
| Flow Cytometry | 2 | 2021 | 664 | 0.060 |
Why?
|
| Mucin 5AC | 1 | 2025 | 9 | 0.060 |
Why?
|
| Interleukin-12 | 1 | 2005 | 127 | 0.060 |
Why?
|
| Antibodies, Bacterial | 1 | 2006 | 181 | 0.060 |
Why?
|
| Peroxidase | 1 | 2005 | 70 | 0.050 |
Why?
|
| Receptors, CCR5 | 1 | 2005 | 59 | 0.050 |
Why?
|
| Ovalbumin | 1 | 2025 | 108 | 0.050 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2004 | 12 | 0.050 |
Why?
|
| Biocompatible Materials | 1 | 2006 | 154 | 0.050 |
Why?
|
| Immune Tolerance | 1 | 2005 | 186 | 0.050 |
Why?
|
| Chemokine CXCL13 | 1 | 2024 | 8 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 118 | 0.050 |
Why?
|
| Iodine Radioisotopes | 1 | 2003 | 60 | 0.050 |
Why?
|
| Endotoxins | 1 | 2003 | 81 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2024 | 209 | 0.050 |
Why?
|
| Chemotactic Factors | 1 | 2002 | 25 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2025 | 423 | 0.050 |
Why?
|
| T-Lymphocytes | 2 | 2023 | 1010 | 0.050 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2024 | 145 | 0.050 |
Why?
|
| Mice, Inbred C3H | 3 | 2009 | 173 | 0.050 |
Why?
|
| Mice, Mutant Strains | 2 | 2013 | 301 | 0.050 |
Why?
|
| Virulence | 2 | 2017 | 199 | 0.040 |
Why?
|
| RNA, Ribosomal | 1 | 2002 | 60 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2022 | 69 | 0.040 |
Why?
|
| Base Sequence | 2 | 2017 | 1331 | 0.040 |
Why?
|
| Tuberculosis | 1 | 2005 | 314 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2021 | 233 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2021 | 139 | 0.040 |
Why?
|
| Spleen | 1 | 2002 | 476 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 211 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 432 | 0.040 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2005 | 424 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2017 | 1042 | 0.040 |
Why?
|
| Leukocyte Disorders | 1 | 2019 | 2 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2003 | 662 | 0.040 |
Why?
|
| Monocytes | 1 | 2022 | 361 | 0.040 |
Why?
|
| Immune System Diseases | 1 | 2019 | 19 | 0.040 |
Why?
|
| Kidney | 1 | 2002 | 458 | 0.040 |
Why?
|
| Cell Communication | 1 | 2019 | 135 | 0.040 |
Why?
|
| Phosphorylation | 3 | 2007 | 963 | 0.040 |
Why?
|
| Models, Biological | 2 | 2017 | 1193 | 0.040 |
Why?
|
| Histones | 1 | 2022 | 497 | 0.030 |
Why?
|
| Thyroid Nuclear Factor 1 | 1 | 2017 | 4 | 0.030 |
Why?
|
| Pulmonary Surfactants | 1 | 2017 | 14 | 0.030 |
Why?
|
| Cell Self Renewal | 1 | 2017 | 13 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 449 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2017 | 30 | 0.030 |
Why?
|
| Cellular Microenvironment | 1 | 2017 | 23 | 0.030 |
Why?
|
| Serogroup | 1 | 2017 | 35 | 0.030 |
Why?
|
| Cell Separation | 1 | 2017 | 147 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 2017 | 104 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2017 | 257 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2017 | 87 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 2016 | 52 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 237 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2017 | 183 | 0.030 |
Why?
|
| Butyrate Response Factor 1 | 1 | 2014 | 1 | 0.030 |
Why?
|
| Interleukin-23 Subunit p19 | 2 | 2005 | 3 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2016 | 198 | 0.030 |
Why?
|
| Interleukin-23 | 2 | 2005 | 18 | 0.030 |
Why?
|
| Epithelium | 1 | 2014 | 100 | 0.030 |
Why?
|
| Child | 1 | 2023 | 4634 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2013 | 35 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2013 | 46 | 0.020 |
Why?
|
| United States | 1 | 2025 | 8166 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 606 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 196 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2011 | 45 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2012 | 142 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2011 | 52 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2011 | 41 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2011 | 116 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 316 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 193 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2011 | 147 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2011 | 541 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 672 | 0.020 |
Why?
|
| UDPglucose-Hexose-1-Phosphate Uridylyltransferase | 1 | 2009 | 1 | 0.020 |
Why?
|
| Transfection | 1 | 2011 | 700 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2011 | 398 | 0.020 |
Why?
|
| RNA Stability | 1 | 2009 | 104 | 0.020 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2009 | 145 | 0.020 |
Why?
|
| RNA | 1 | 2011 | 427 | 0.020 |
Why?
|
| Chemokine CXCL11 | 1 | 2007 | 4 | 0.020 |
Why?
|
| Chemokine CXCL9 | 1 | 2007 | 23 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 54 | 0.020 |
Why?
|
| Interleukin-1alpha | 1 | 2007 | 25 | 0.020 |
Why?
|
| Chemokine CXCL10 | 1 | 2007 | 56 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2007 | 62 | 0.020 |
Why?
|
| Cell Count | 1 | 2007 | 128 | 0.020 |
Why?
|
| Aged | 1 | 2023 | 15089 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2007 | 156 | 0.020 |
Why?
|
| Respiration | 1 | 2007 | 97 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2009 | 436 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2007 | 213 | 0.010 |
Why?
|
| Staphylococcus epidermidis | 1 | 2006 | 11 | 0.010 |
Why?
|
| Enterococcus faecalis | 1 | 2006 | 11 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 1588 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 1979 | 0.010 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 274 | 0.010 |
Why?
|
| Materials Testing | 1 | 2006 | 89 | 0.010 |
Why?
|
| Chemokine CCL3 | 1 | 2005 | 8 | 0.010 |
Why?
|
| Chemokine CCL5 | 1 | 2005 | 32 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 491 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 42 | 0.010 |
Why?
|
| Granuloma | 1 | 2005 | 43 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 46 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2005 | 65 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2006 | 183 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2005 | 170 | 0.010 |
Why?
|
| Keratinocytes | 1 | 2005 | 76 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2006 | 257 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 301 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 401 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2005 | 237 | 0.010 |
Why?
|
| Protein Binding | 1 | 2009 | 1633 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 542 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 611 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2005 | 321 | 0.010 |
Why?
|
| Mutation | 1 | 2011 | 2670 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2003 | 104 | 0.010 |
Why?
|
| CD18 Antigens | 1 | 2002 | 30 | 0.010 |
Why?
|
| Injections, Spinal | 1 | 2002 | 44 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2003 | 169 | 0.010 |
Why?
|
| Glucose | 1 | 2005 | 478 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 241 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2003 | 434 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2003 | 531 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2003 | 679 | 0.010 |
Why?
|